{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T20:52:19Z","timestamp":1783716739296,"version":"3.55.0"},"reference-count":89,"publisher":"SAGE Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2020,11,10]]},"abstract":"<jats:p>Background: Alzheimer\u2019s disease (AD), the prevalent dementia in the elderly, involves many related and interdependent pathologies that manifest simultaneously, leading to cognitive impairment and death. Amyloid-\u03b2 (A\u03b2) accumulation in the brain triggers the onset of AD, accompanied by neuroinflammatory response and pathological changes. The CXCR4\/CXCL12 (SDF1) axis is one of the major signal transduction cascades involved in the inflammation process and regulation of homing of hematopoietic stem cells (HSCs) within the bone marrow niche. Inhibition of the axis with AMD3100, a reversible antagonist of CXCR4 mobilizes endogenous HSCs from the bone marrow into the periphery, facilitating the recruitment of bone marrow-derived microglia-like cells into the brain, attenuates the neuroinflammation process that involves release of excitotoxic markers such as TNF\u03b1, intracellular Ca2\u00a0+, and glutamate and upregulates monocarboxylate transporter 1, the major L-lactate transporter in the brain. Objective: Herein, we investigate if administration of a combination of AMD3100 and L-lactate may have beneficial effects in the treatment of AD. Methods: We tested the feasibility of the combined treatment for short- and long-term efficacy for inducing endogenous stem cells\u2019 mobilization and attenuation of neuroinflammation in two distinct amyloid-\u03b2-induced AD mouse models. Results: The combined treatment did not demonstrate any adverse effects on the mice, and resulted in a significant improvement in cognitive\/memory functions, attenuated neuroinflammation, and alleviated AD pathologies compared to each treatment alone. Conclusion: This study showed AMD3100\u2019s beneficial effect in ameliorating AD pathogenesis, suggesting an alternative to the multistep procedures of transplantation of stem cells in the treatment of AD.<\/jats:p>","DOI":"10.3233\/jad-200506","type":"journal-article","created":{"date-parts":[[2020,10,2]],"date-time":"2020-10-02T13:58:41Z","timestamp":1601647121000},"page":"653-671","source":"Crossref","is-referenced-by-count":24,"title":["Subcutaneous Administration of AMD3100 into Mice Models of Alzheimer\u2019s Disease Ameliorated Cognitive Impairment, Reduced Neuroinflammation, and Improved Pathophysiological Markers"],"prefix":"10.1177","volume":"78","author":[{"given":"Yuval","family":"Gavriel","sequence":"first","affiliation":[{"name":"The Shmunis School of Biomedicine and Cancer Research, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inna","family":"Rabinovich-Nikitin","sequence":"additional","affiliation":[{"name":"The Shmunis School of Biomedicine and Cancer Research, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assaf","family":"Ezra","sequence":"additional","affiliation":[{"name":"The Shmunis School of Biomedicine and Cancer Research, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Becki","family":"Barbiro","sequence":"additional","affiliation":[{"name":"The Shmunis School of Biomedicine and Cancer Research, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beka","family":"Solomon","sequence":"additional","affiliation":[{"name":"The Shmunis School of Biomedicine and Cancer Research, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-200506_ref1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14748\/bmr.v22.30","article-title":"From bone marrow to brain: Stem cells in neuroprotection, plasticity, and neuroregeneration","volume":"22","author":"Penkowa","year":"2011","journal-title":"Biomed Rev"},{"key":"10.3233\/JAD-200506_ref2","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.bbadis.2015.09.017","article-title":"Bone marrow-derived macrophages and the CNS: An update on the use of experimental chimeric mouse models and bone marrow transplantation in neurological disorders","volume":"1862","author":"Larochelle","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.3233\/JAD-200506_ref3","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.neuron.2006.01.022","article-title":"Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer\u2019s disease","volume":"49","author":"Simard","year":"2006","journal-title":"Neuron"},{"key":"10.3233\/JAD-200506_ref4","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3233\/JAD-170994","article-title":"Bone-marrow-derived microglia-like cells ameliorate brain amyloid pathology and cognitive impairment in a mouse model of Alzheimer\u2019s disease","volume":"64","author":"Kawanishi","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-200506_ref5","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3233\/JAD-181249","article-title":"The potential influence of bone-derived modulators on the progression of Alzheimer\u2019s disease","volume":"69","author":"Yuan","year":"2019","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-200506_ref6","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3389\/fendo.2019.00585","article-title":"The role of the CXCL12\/CXCR4\/ACKR3 axis in autoimmune diseases","volume":"10","author":"Garc\u00eda-Cuesta","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.3233\/JAD-200506_ref7","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1177\/1073858416685690","article-title":"CXCL12\/CXCR4\/CXCR7 chemokine axis in the central nervous system: Therapeutic targets for remyelination in demyelinating diseases","volume":"23","author":"Chu","year":"2017","journal-title":"Neuroscientist"},{"key":"10.3233\/JAD-200506_ref8","doi-asserted-by":"crossref","first-page":"11125","DOI":"10.1523\/JNEUROSCI.2545-05.2005","article-title":"Invasion of hematopoietic cells into the brain of amyloid precursor protein transgenic mice","volume":"25","author":"Stalder","year":"2005","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-200506_ref9","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3389\/fncel.2014.00065","article-title":"CXCL12 chemokine and its receptors as major players in the interactions between immune and nervous systems","volume":"8","author":"Guyon","year":"2014","journal-title":"Front Cell Neurosci"},{"key":"10.3233\/JAD-200506_ref10","doi-asserted-by":"crossref","first-page":"480739","DOI":"10.1155\/2013\/480739","article-title":"Cytokines and chemokines at the crossroads of neuroinflammation, neurodegeneration, and neuropathic pain","volume":"2013","author":"Ramesh","year":"2013","journal-title":"Mediators Inflamm"},{"key":"10.3233\/JAD-200506_ref11","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1006\/frne.2001.0214","article-title":"Chemokines and their receptors in the central nervous system","volume":"22","author":"Bajetto","year":"2001","journal-title":"Front Neuroendocrinol"},{"key":"10.3233\/JAD-200506_ref12","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.yexcr.2006.10.028","article-title":"Alterations in immunological and neurological gene expression patterns in Alzheimer\u2019s disease tissues","volume":"313","author":"Weeraratna","year":"2007","journal-title":"Exp Cell Res"},{"key":"10.3233\/JAD-200506_ref13","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/89490","article-title":"CXCR4-activated astrocyte glutamate release via TNFalpha: Amplification by microglia triggers neurotoxicity","volume":"4","author":"Bezzi","year":"2001","journal-title":"Nat Neurosci"},{"key":"10.3233\/JAD-200506_ref14","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/jnc.12985","article-title":"Retracted: CXCL12\/CXCR4 chemokine signaling in spinal glia induces pain hypersensitivity through MAPKs-mediated neuroinflammation in bone cancer rats","volume":"132","author":"Hu","year":"2015","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-200506_ref15","doi-asserted-by":"crossref","first-page":"e0163807","DOI":"10.1371\/journal.pone.0163807","article-title":"Down-regulation of CXCL12\/CXCR4 expression alleviates ischemia-reperfusion-induced inflammatory pain via inhibiting glial TLR4 activation in the spinal cord","volume":"11","author":"Li","year":"2016","journal-title":"PLoS One"},{"key":"10.3233\/JAD-200506_ref16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41398-017-0049-7","article-title":"CXCR4 involvement in neurodegenerative diseases","volume":"8","author":"Bonham","year":"2018","journal-title":"Transl Psychiatry"},{"key":"10.3233\/JAD-200506_ref17","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.tins.2012.06.003","article-title":"Chemokine CXCL12 in neurodegenerative diseases: An SOS signal for stem cell-based repair","volume":"35","author":"Li","year":"2012","journal-title":"Trends Neurosci"},{"key":"10.3233\/JAD-200506_ref18","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/TA.0b013e318222f380","article-title":"Impact of enhanced mobilization of bone marrow derived cells to site of injury","volume":"71","author":"Hannoush","year":"2011","journal-title":"J Trauma"},{"key":"10.3233\/JAD-200506_ref19","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.arr.2016.11.002","article-title":"Stem cell therapies in age-related neurodegenerative diseases and stroke","volume":"34","author":"Wang","year":"2017","journal-title":"Ageing Res Rev"},{"key":"10.3233\/JAD-200506_ref20","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.3727\/096368913X665576","article-title":"Efficacy and safety of autologous bone marrow-derived stem cell transplantation in patients with type 2 diabetes mellitus: A randomized placebo-controlled study","volume":"23","author":"Bhansali","year":"2014","journal-title":"Cell Transplant"},{"key":"10.3233\/JAD-200506_ref21","doi-asserted-by":"crossref","DOI":"10.1177\/2040206619829382","article-title":"Mozobil\u00ae (Plerixafor, AMD3100), 10 years after its approval by the US Food and Drug Administration","volume":"27","author":"De Clercq","year":"2019","journal-title":"Antivir Chem Chemother"},{"key":"10.3233\/JAD-200506_ref22","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40164-016-0050-5","article-title":"Effectiveness of AMD3100 in treatment of leukemia and solid tumors: From original discovery to use in current clinical practice","volume":"5","author":"Liu","year":"2016","journal-title":"Ex Hematol Oncol"},{"key":"10.3233\/JAD-200506_ref23","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1074\/jbc.M309546200","article-title":"Molecular mechanism of AMD3100 antagonism in the CXCR4 receptor: Transfer of binding site to the CXCR3 receptor","volume":"279","author":"Rosenkilde","year":"2004","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-200506_ref24","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1128\/AAC.44.6.1667-1673.2000","article-title":"Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers","volume":"44","author":"Hendrix","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.3233\/JAD-200506_ref26","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/jcbfm.2014.206","article-title":"Lactate transport and signaling in the brain: Potential therapeutic targets and roles in body\u2013brain interaction","volume":"35","author":"Bergersen","year":"2014","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.3233\/JAD-200506_ref27","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1016\/j.bbamcr.2016.03.013","article-title":"Monocarboxylate transporters in the brain and in cancer","volume":"1863","author":"P\u00e9rez-Escuredo","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.3233\/JAD-200506_ref28","doi-asserted-by":"crossref","first-page":"923670","DOI":"10.1155\/2014\/923670","article-title":"Correlated inflammatory responses and neurodegeneration in peptide-injected animal models of Alzheimer\u2019s disease","volume":"2014","author":"McLarnon","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.3233\/JAD-200506_ref29","first-page":"7247","article-title":"An in vivo model for the neurodegenerative effects of f8 amyloid and protection by substance P","volume":"88","author":"Kowall","year":"1991","journal-title":"Neurobiology"},{"key":"10.3233\/JAD-200506_ref30","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1097\/00001756-200308060-00005","article-title":"Amyloid beta peptide-induced corpus callosum damage and glial activation in vivo","volume":"14","author":"Jantaratnotai","journal-title":"Neuroreport"},{"key":"10.3233\/JAD-200506_ref31","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.neuropharm.2010.02.009","article-title":"DHEA prevents A\u03b225-35-impaired survival of newborn neurons in the dentate gyrus through a modulation of PI3K-Akt-mTOR signaling","volume":"59","author":"Li","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.3233\/JAD-200506_ref32","first-page":"53308","article-title":"Intracerebroventricular injection of amyloid peptides in normal mice to acutely induce Alzheimer-like cognitive deficits","volume":"109","author":"Kim","year":"2016","journal-title":"J Vis Exp"},{"key":"10.3233\/JAD-200506_ref33","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.brainres.2010.05.013","article-title":"Characterization of the 3xTg-AD mouse model of Alzheimer\u2019s disease: Part 1. Circadian changes","volume":"1348","author":"Sterniczuk","year":"2010","journal-title":"Brain Res"},{"key":"10.3233\/JAD-200506_ref34","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0166-4328(99)00186-2","article-title":"Contextual fear, gestalt memories, and the hippocampus","volume":"110","author":"Fanselow","year":"2000","journal-title":"Behav Brain Res"},{"key":"10.3233\/JAD-200506_ref35","doi-asserted-by":"crossref","first-page":"6755","DOI":"10.1523\/JNEUROSCI.1247-05.2005","article-title":"Conditional inactivation of presenilin 1 prevents amyloid accumulation and temporarily rescues contextual and spatial working memory impairments in amyloid precursor protein transgenic mice","volume":"25","author":"Saura","year":"2005","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-200506_ref36","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1074\/jbc.M112.409250","article-title":"Inhibition of glycogen synthase kinase-3 ameliorates \u03b2-amyloid pathology and restores lysosomal acidification and mammalian target of rapamycin activity in the Alzheimer disease mouse model: in vivo and in vitro studies","volume":"288","author":"Avrahami","year":"2013","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-200506_ref37","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1084\/jem.20140413","article-title":"Restored glial glutamate transporter EAAT2 function as a potential therapeutic approach for Alzheimer\u2019s disease","volume":"212","author":"Takahashi","year":"2015","journal-title":"J Exp Med"},{"key":"10.3233\/JAD-200506_ref38","doi-asserted-by":"crossref","first-page":"21800","DOI":"10.1073\/pnas.1903566116","article-title":"Divergent roles of astrocytic versus neuronal EAAT2 deficiency on cognition and overlap with aging and Alzheimer\u2019s molecular signatures","volume":"116","author":"Sharma","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-200506_ref39","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1001\/archneur.58.3.365","article-title":"Glutamate transporters in neurologic disease","volume":"58","author":"Maragakis","year":"2001","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-200506_ref40","doi-asserted-by":"crossref","first-page":"553.e1","DOI":"10.1016\/j.neurobiolaging.2010.03.008","article-title":"Glutamate transporter variants reduce glutamate uptake in Alzheimer\u2019s disease","volume":"32","author":"Scott","year":"2011","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-200506_ref41","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1182\/blood.V80.12.3044.3044","article-title":"In vivo and in vitro stem cell function of c-kit- and Sca-1-positive murine hematopoietic cells","volume":"80","author":"Okada","year":"1992","journal-title":"Blood"},{"key":"10.3233\/JAD-200506_ref42","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/j.stemcr.2017.04.012","article-title":"SCA-1 expression level identifies quiescent hematopoietic stem and progenitor cells","volume":"8","author":"Morcos","year":"2017","journal-title":"Stem Cell Rep"},{"key":"10.3233\/JAD-200506_ref43","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40478-018-0515-3","article-title":"White matter changes in Alzheimer\u2019s disease: A focus on myelin and oligodendrocytes","volume":"6","author":"Nasrabady","year":"2018","journal-title":"Acta Neuropathol Commun"},{"key":"10.3233\/JAD-200506_ref44","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.jalz.2017.09.012","article-title":"Conserved brain myelination networks are altered in Alzheimer\u2019s and other neurodegenerative diseases","volume":"14","author":"Allen","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-200506_ref45","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/glia.20734","article-title":"Triple-transgenic Alzheimer\u2019s disease mice exhibit region-specific abnormalities in brain myelination patterns prior to appearance of amyloid and tau pathology","volume":"57","author":"Desai","year":"2009","journal-title":"Glia"},{"key":"10.3233\/JAD-200506_ref46","doi-asserted-by":"crossref","first-page":"908","DOI":"10.4103\/1673-5374.232486","article-title":"Association between Alzheimer\u2019s disease pathogenesis and early demyelination and oligodendrocyte dysfunction","volume":"13","author":"Dong","year":"2018","journal-title":"Neural Regen Res"},{"key":"10.3233\/JAD-200506_ref47","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1007\/s00018-006-6094-7","article-title":"Myelin basic protein: A multifunctional protein","volume":"63","author":"Boggs","year":"2006","journal-title":"Cell Mol Life Sci"},{"key":"10.3233\/JAD-200506_ref48","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3389\/fncel.2018.00215","article-title":"Microglia responses to pro-inflammatory stimuli (LPS, IFN\u03b3+TNF\u03b1) and reprogramming by resolving cytokines (IL-4, IL-10)","volume":"12","author":"Lively","year":"2018","journal-title":"Front Cell Neurosci"},{"key":"10.3233\/JAD-200506_ref49","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1742-2094-3-27","article-title":"Expression profiles for macrophage alternative activation genes in AD and in mouse models of AD","volume":"3","author":"Colton","year":"2006","journal-title":"J. Neuroinflammation"},{"key":"10.3233\/JAD-200506_ref50","doi-asserted-by":"crossref","first-page":"693851","DOI":"10.1155\/2014\/693851","article-title":"Proliferation in the Alzheimer hippocampus is due to microglia, not astroglia, and occurs at sites of amyloid deposition","volume":"2014","author":"Marlatt","year":"2014","journal-title":"Neural Plast"},{"key":"10.3233\/JAD-200506_ref51","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/nri2448","article-title":"Exploring the full spectrum of macrophage activation","volume":"8","author":"Mosser","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.3233\/JAD-200506_ref52","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/00005072-199708000-00011","article-title":"Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer disease","volume":"56","author":"Sze","year":"1997","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.3233\/JAD-200506_ref53","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev.neuro.24.1.677","article-title":"Neurotrophins: Roles in neuronal development and function","volume":"24","author":"Huang","year":"2001","journal-title":"Annu Rev Neurosci"},{"key":"10.3233\/JAD-200506_ref54","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1750-1326-5-7","article-title":"GSK3 and p53 \u2013Is there a link in Alzheimer\u2019s disease?","volume":"5","author":"Proctor","year":"2010","journal-title":"Mol Neurodegener"},{"key":"10.3233\/JAD-200506_ref55","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1006\/bbrc.1997.6301","article-title":"Changes of p53 in the brains of patients with Alzheimer\u2019s disease","volume":"232","author":"Kitamura","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"10.3233\/JAD-200506_ref56","first-page":"46","article-title":"GSK-3\u03b2, a pivotal kinase in Alzheimer disease","volume":"7","author":"Llorens-Mart\u00edn","year":"2014","journal-title":"Front Mol Neurosci"},{"key":"10.3233\/JAD-200506_ref57","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1600-079X.2010.00747.x","article-title":"Amyloid-\u03b2 neurotoxicity in organotypic culture is attenuated by melatonin: Involvement of GSK-3\u03b2, tau and neuroinflammation","volume":"48","author":"Hoppe","year":"2010","journal-title":"J Pineal Res"},{"key":"10.3233\/JAD-200506_ref58","doi-asserted-by":"crossref","first-page":"9733","DOI":"10.1523\/JNEUROSCI.22-22-09733.2002","article-title":"Tau-mediated cytotoxicity in a pseudohyperphosphorylation model of Alzheimer\u2019s disease","volume":"22","author":"Fath","year":"2002","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-200506_ref59","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s40478-017-0458-0","article-title":"Generation and characterization of new monoclonal antibodies targeting the PHF1 and AT8 epitopes on human tau","volume":"5","author":"Strang","year":"2017","journal-title":"Acta Neuropathol Commun"},{"key":"10.3233\/JAD-200506_ref60","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.2353\/ajpath.2008.080528","article-title":"Chronic neuron-specific tumor necrosis factor-alpha expression enhances the local inflammatory environment ultimately leading to neuronal death in 3xTg-AD mice","volume":"173","author":"Janelsins","year":"2008","journal-title":"Am J Pathol"},{"key":"10.3233\/JAD-200506_ref61","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1742-2094-9-99","article-title":"Early intervention with a small molecule inhibitor for tumor necrosis factor-\u03b1 prevents cognitive deficits in a triple transgenic mouse model of Alzheimer\u2019s disease","volume":"9","author":"Gabbita","year":"2012","journal-title":"J Neuroinflammation"},{"key":"10.3233\/JAD-200506_ref62","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1212\/WNL.0b013e3181b6bb95","article-title":"Systemic inflammation and disease progression in Alzheimer disease","volume":"3","author":"Holmes","year":"2009","journal-title":"Neurology"},{"key":"10.3233\/JAD-200506_ref63","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/1742-2094-9-106","article-title":"Tumor necrosis factor-\u03b1 synthesis inhibitor 3,6\u2019-dithiothalidomide attenuates markers of inflammation, Alzheimer pathology and behavioral deficits in animal models of neuroinflammation and Alzheimer\u2019s disease","volume":"9","author":"Tweedie","year":"2012","journal-title":"J Neuroinflammation"},{"key":"10.3233\/JAD-200506_ref64","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.nbd.2009.01.006","article-title":"Inhibition of soluble TNF signaling in a mouse model of Alzheimer\u2019s disease prevents pre-plaque amyloid-associated neuropathology","volume":"34","author":"McAlpine","year":"2009","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JAD-200506_ref65","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.brainres.2010.10.053","article-title":"Anti-TNF-\u03b1 reduces amyloid plaques and tau phosphorylation and induces CD11c-positive dendritic-like cell in the APP\/PS1 transgenic mouse brains","volume":"1368","author":"Shi","year":"2011","journal-title":"Brain Res"},{"key":"10.3233\/JAD-200506_ref66","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.pneurobio.2013.06.004","article-title":"Decoding Alzheimer\u2019s disease from perturbed cerebral glucose metabolism: Implications for diagnostic and therapeutic strategies","volume":"108","author":"Chen","year":"2013","journal-title":"Prog Neurobiol"},{"key":"10.3233\/JAD-200506_ref67","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1093\/jnen\/nly102","article-title":"Lactate deficit in an Alzheimer disease mouse model: The relationship with neuronal damage","volume":"77","author":"Zhang","year":"2018","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.3233\/JAD-200506_ref68","doi-asserted-by":"crossref","first-page":"430","DOI":"10.2337\/diabetes.51.2.430","article-title":"Synaptic adaptation to repeated hypoglycemia depends on the utilization of monocarboxylates in guinea pig hippocampal slices","volume":"51","author":"Sakurai","year":"2002","journal-title":"Diabetes"},{"key":"10.3233\/JAD-200506_ref69","first-page":"112","article-title":"Glycolysis and the significance of lactate in traumatic brain injury","volume":"9","author":"Schurr","year":"2015","journal-title":"Front Neurosci"},{"key":"10.3233\/JAD-200506_ref70","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.cell.2011.02.018","article-title":"Astrocyte-neuron lactate transport is required for long-term memory formation","volume":"144","author":"Suzuki","year":"2011","journal-title":"Cell"},{"key":"10.3233\/JAD-200506_ref71","doi-asserted-by":"crossref","first-page":"21250","DOI":"10.1038\/srep21250","article-title":"L-Lactate protects neurons against excitotoxicity: Implication of an ATP-mediated signaling cascade","volume":"6","author":"Jourdain","year":"2016","journal-title":"Sci Rep"},{"key":"10.3233\/JAD-200506_ref72","doi-asserted-by":"crossref","first-page":"54","DOI":"10.2174\/138920310790274626","article-title":"Conformations and biological activities of amyloid beta peptide 25-35","volume":"11","author":"Millucci","year":"2010","journal-title":"Curr Protein Pept Sci"},{"key":"10.3233\/JAD-200506_ref73","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1196\/annals.1395.056","article-title":"The effect of intrahippocampal beta amyloid (1\u201342) peptide injection on oxidant and antioxidant status in rat brain","volume":"1100","author":"Cetin","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.3233\/JAD-200506_ref74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/798535","article-title":"Protective effects ofextract on amyloid \u03b2-peptide(25\u201335)-induced memory impairment in male rats: A behavioral study","volume":"2014","author":"Ghahremanitamadon","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.3233\/JAD-200506_ref75","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2174\/156720508785908874","article-title":"Relevance of abeta1\u201342 intrahippocampal injection as an animal model of inflamed Alzheimer\u2019s disease brain","volume":"5","author":"McLarnon","year":"2008","journal-title":"Curr Alzheimer Res"},{"key":"10.3233\/JAD-200506_ref76","first-page":"811","article-title":"Ameliorating of memory impairment and apoptosis in amyloid \u03b2-injected rats via inhibition of nitric oxide synthase: Possible participation of autophagy","volume":"14","author":"Shariatpanahi","year":"2015","journal-title":"Iran J Pharm Res"},{"key":"10.3233\/JAD-200506_ref77","first-page":"43","article-title":"A derangement of the brain wound healing process may cause some cases of Alzheimer\u2019s disease","volume":"22","author":"Lehrer","year":"2016","journal-title":"Discov Med"},{"key":"10.3233\/JAD-200506_ref78","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.pneurobio.2018.05.001","article-title":"The interactions of p53 with tau and A\u00df represent potential therapeutic targets for Alzheimer\u2019s disease","volume":"168","author":"Jembrek","year":"2018","journal-title":"Prog Neurobiol"},{"key":"10.3233\/JAD-200506_ref79","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000353749","article-title":"Inhibition of amyloid precursor protein processing leads to downregulation of apoptotic genes in Alzheimer\u2019s disease animal models","volume":"13","author":"Rabinovich-Nikitin","year":"2014","journal-title":"Neurodegener Dis"},{"key":"10.3233\/JAD-200506_ref80","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1016\/j.bbi.2010.12.018","article-title":"Targeting the hematopoietic system for the treatment of Alzheimer\u2019s disease","volume":"25","author":"Lampron","year":"2011","journal-title":"Brain Behav Immun"},{"key":"10.3233\/JAD-200506_ref81","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1038\/ncomms2536","article-title":"Haematopoietic cells produce BDNF and regulate appetite upon migration to the hypothalamus","volume":"4","author":"Urabe","year":"2013","journal-title":"Nat Commun"},{"key":"10.3233\/JAD-200506_ref82","doi-asserted-by":"crossref","first-page":"33568","DOI":"10.18632\/oncotarget.5598","article-title":"Effective impairment of myeloma cells and their progenitors by blockade of monocarboxylate transportation","volume":"6","author":"Hanson","year":"2015","journal-title":"Oncotarget"},{"key":"10.3233\/JAD-200506_ref83","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3389\/fnmol.2018.00375","article-title":"L-lactate regulates the expression of synaptic plasticity and neuroprotection genes in cortical neurons: A transcriptome analysis","volume":"11","author":"Margineanu","year":"2018","journal-title":"Front Mol Neurosci"},{"key":"10.3233\/JAD-200506_ref84","doi-asserted-by":"crossref","first-page":"283","DOI":"10.31887\/DCNS.2018.20.4\/knave","article-title":"An emerging role of dysfunctional axon-oligodendrocyte coupling in neurodegenerative diseases","volume":"20","author":"Mot","year":"2018","journal-title":"Dialogues Clin Neurosci"},{"key":"10.3233\/JAD-200506_ref85","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1158\/0008-5472.CAN-11-2474","article-title":"Regulation of monocarboxylate transporter MCT1 expression by p53 mediates inward and outward lactate fluxes in tumors","volume":"72","author":"Boidot","year":"2012","journal-title":"Cancer Res"},{"key":"10.3233\/JAD-200506_ref86","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1038\/leu.2008.238","article-title":"The CXCR4 antagonist AMD3100 impairs survival of human AML cells and induces their differentiation","volume":"22","author":"Tavor","year":"2008","journal-title":"Leukemia"},{"key":"10.3233\/JAD-200506_ref87","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.4155\/fmc.12.122","article-title":"Glutamate transporter EAAT2: A new target for the treatment of neurodegenerative diseases","volume":"4","author":"Lin","year":"2012","journal-title":"Future Med Chem"},{"key":"10.3233\/JAD-200506_ref88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0011316","article-title":"Selective enhancement of donor hematopoietic cell engraftment by the CXCR4 antagonist AMD3100 in a mouse transplantation model","volume":"5","author":"Kang","year":"2010","journal-title":"PLoS One"},{"key":"10.3233\/JAD-200506_ref89","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12974-016-0587-6","article-title":"Chronic administration of AMD3100 increases survival and alleviates pathology in SOD1G93A mice model of ALS","volume":"13","author":"Rabinovich-Nikitin","year":"2016","journal-title":"J Neuroinflammation"},{"key":"10.3233\/JAD-200506_ref90","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.bbmt.2008.10.018","article-title":"Pharmacokinetics and pharmacodynamics of Plerixafor in patients with non-Hodgkin lymphoma and multiple myeloma","volume":"15","author":"Stewart","year":"2009","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-200506","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:09:07Z","timestamp":1777370947000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-200506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,10]]},"references-count":89,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/jad-200506","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,10]]}}}